| __timestamp | ADMA Biologics, Inc. | Alnylam Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 190249000 |
| Thursday, January 1, 2015 | 7015946 | 276495000 |
| Friday, January 1, 2016 | 7688238 | 382392000 |
| Sunday, January 1, 2017 | 6229587 | 390635000 |
| Monday, January 1, 2018 | 3926120 | 505420000 |
| Tuesday, January 1, 2019 | 2343848 | 655114000 |
| Wednesday, January 1, 2020 | 5907013 | 654819000 |
| Friday, January 1, 2021 | 3646060 | 792156000 |
| Saturday, January 1, 2022 | 3613764 | 883015000 |
| Sunday, January 1, 2023 | 3300000 | 1004415000 |
| Monday, January 1, 2024 | 1126232000 |
Unleashing the power of data
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Alnylam Pharmaceuticals, Inc. and ADMA Biologics, Inc. offer a fascinating contrast in their R&D allocations over the past decade.
Since 2014, Alnylam has consistently increased its R&D budget, culminating in a staggering 428% rise by 2023. This growth underscores Alnylam's aggressive pursuit of cutting-edge therapies, positioning it as a leader in RNA interference technology.
Conversely, ADMA Biologics has seen a 65% decrease in R&D spending over the same period. This reduction may reflect strategic shifts or financial constraints, highlighting the challenges smaller biotechs face in sustaining innovation.
These trends reveal the dynamic nature of biotech investments and the varying strategies companies employ to navigate the ever-evolving landscape of medical research.
Comparing Innovation Spending: AstraZeneca PLC and Alnylam Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Amgen Inc. vs ADMA Biologics, Inc.
R&D Spending Showdown: Alnylam Pharmaceuticals, Inc. vs BeiGene, Ltd.
Comparing Innovation Spending: Alnylam Pharmaceuticals, Inc. and Jazz Pharmaceuticals plc
Comparing Innovation Spending: Alnylam Pharmaceuticals, Inc. and Axsome Therapeutics, Inc.
Alnylam Pharmaceuticals, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Incyte Corporation vs ADMA Biologics, Inc.
Sarepta Therapeutics, Inc. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for ADMA Biologics, Inc. and Vericel Corporation
Comparing Innovation Spending: ADMA Biologics, Inc. and Ligand Pharmaceuticals Incorporated
Research and Development Expenses Breakdown: ADMA Biologics, Inc. vs Agios Pharmaceuticals, Inc.
Research and Development Investment: ADMA Biologics, Inc. vs Wave Life Sciences Ltd.